+34.2%
MRNA vs BTSG
+382.3%
-348.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BTSG | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -6.6% | +7.4% | +2.2% |
| 7D | -8.2% | -5.8% | -2.4% | -7.1% |
| 30D | +125.6% | 0.0% | +125.6% | +124.2% |
| 3M | +197.1% | -4.5% | +201.5% | +197.3% |
| 6M | +148.5% | +40.0% | +108.5% | +124.2% |
| YTD | +363.3% | +54.6% | +308.7% | +308.3% |
| 1Y | +462.0% | +106.1% | +355.9% | +363.6% |
| All | +34.2% | +382.3% | -348.1% | -25.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BTSG.
Daily Out/Under-Performance
Portfolio return minus BTSG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BTSG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BTSG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling